Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ipsen
Sort By
Newest First
1 / 1
1 / 1
Announcement
French Pharma Company Ipsen Moves US Headquarters from New Jersey to Boston
Guy Tiene
Nice Insight
PAO-M06-18-NI-013
Jun 15, 2018
Strategic Partnership
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership
Ipsen
PR-M06-18-NI-001
Jun 01, 2018
EMA
Ipsen Announces EMA Validation of Filing of a New Application for Additional Indication for Cabometyx®
Ipsen
PR-M03-18-NI-104-4486
Mar 29, 2018
Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma
Ipsen
PR-M03-18-NI-096
Mar 27, 2018
